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Background: The vestibular system controls the ion composition of its luminal fluid through several epithelial cell
transport mechanisms under hormonal regulation. The semicircular canal duct (SCCD) epithelium has been shown
to secrete Cl- under β2-adrenergic stimulation. In the current study, we sought to determine the ion transporters
involved in Cl- secretion and whether secretion is regulated by PKA and glucocorticoids.
Results: Short circuit current (Isc) from rat SCCD epithelia demonstrated stimulation by forskolin (EC50: 0.8 μM),
8-Br-cAMP (EC50: 180 μM), 8-pCPT-cAMP (100 μM), IBMX (250 μM), and RO-20-1724 (100 μM). The PKA activator
N6-BNZ-cAMP (0.1, 0.3 & 1 mM) also stimulated Isc. Partial inhibition of stimulated Isc individually by bumetanide
(10 & 50 μM), and [(dihydroindenyl)oxy]alkanoic acid (DIOA, 100 μM) were additive and complete. Stimulated Isc
was also partially inhibited by CFTRinh-172 (5 & 30 μM), flufenamic acid (5 μM) and diphenylamine-2,20-
dicarboxylic acid (DPC; 1 mM). Native canals of CFTR+/− mice showed a stimulation of Isc from isoproterenol and
forskolin+IBMX but not in the presence of both bumetanide and DIOA, while canals from CFTR−/− mice had no
responses. Nonetheless, CFTR−/− mice showed no difference from CFTR+/− mice in their ability to balance (rota-rod).
Stimulated Isc was greater after chronic incubation (24 hr) with the glucocorticoids dexamethasone (0.1 & 0.3 μM),
prednisolone (0.3, 1 & 3 μM), hydrocortisone (0.01, 0.1 & 1 μM), and corticosterone (0.1 & 1 μM) and mineralocorticoid
aldosterone (1 μM). Steroid action was blocked by mifepristone but not by spironolactone, indicating all the steroids
activated the glucocorticoid, but not mineralocorticoid, receptor. Expression of transcripts for CFTR; for KCC1, KCC3a,
KCC3b and KCC4, but not KCC2; for NKCC1 but not NKCC2 and for WNK1 but only very low WNK4 was determined.
Conclusions: These results are consistent with a model of Cl- secretion whereby Cl- is taken up across the basolateral
membrane by a Na+-K+-2Cl- cotransporter (NKCC) and potentially another transporter, is secreted across the apical
membrane via a Cl- channel, likely CFTR, and demonstrate the regulation of Cl- secretion by protein kinase A and
glucocorticoids.
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Figure 1 Stimulation of equivalent short circuit current (Isc) by
the adenylyl cyclase activator forskolin. (A) Representative
recording of VT from primary cultures of SCCD epithelium with the
effect of forskolin (0.01 to 10 μM) added cumulatively on both sides
at arrows. Downward deflections result from transepithelial current
pulses and are proportional to transepithelial resistance. B) Summary
of concentration-response of Isc to forskolin (FSK) stimulation (n = 3–5),
EC50 = 0.8 μM and Hill coefficient 0.9. Summary data are mean ± SEM;
error bars are smaller than symbols.
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The inner ear controls the ion composition of its luminal
fluid, endolymph, through a multiplicity of transepithelial
transport mechanisms in different cell types bounding the
lumen. The high-K+, low Na+, low Ca2+ endolymph com-
position is needed for proper auditory and vestibular func-
tion [1-3]. K+ secretion by both strial marginal cells and
vestibular dark cells is stimulated by β-adrenergic recep-
tors via cytosolic cAMP as second messenger [4,5]. Secre-
tion of the primary anion, Cl-, is known to also be under
adrenergic control in semicircular canal duct (SCCD)
epithelium [6].
Cl- transport by several epithelia has been shown to be
under control of a cAMP signal pathway that is medi-
ated by apical CFTR Cl- channels via protein kinase A
(PKA) [7]. Vectorial transport in those epithelia depends
also on basolateral Na+-K+-ATPase and K+ channels as
well as basolateral Cl transporters such as the Na+-K+-2Cl-
cotransporter (NKCC1/Slc12a2) [6,8-10]. Cellular cAMP
levels and cAMP-mediated processes, including ion trans-
port, depend on cAMP metabolism regulated by the
enzymatic activity of anabolic adenylyl cyclase and cata-
bolic phosphodiesterase [11-13].
Glucocorticoids can modify cellular responses via
genomic and non-genomic pathways, including regula-
tion of ion transport processes [14-17]. Na+ absorption
by SCCD has already been demonstrated to be stimu-
lated by glucocorticoids [17,18]. There is considerable
evidence in various tissues, including epithelia, that glu-
cocorticoids have long-term (genomic) effects on cAMP
metabolism and potentiate cAMP-mediated responses,
including ion transport by activation of the glucocortic-
oid receptor [19-21].
We therefore sought to determine in SCCD a) whether
there is a basal constitutive adenylyl cyclase activity driving
cAMP-mediated Cl- secretion, b) whether Cl- secretion is
enhanced by glucocorticoid hormones via activation of
glucocorticoid receptors, c) whether Cl- secretion is medi-
ated through PKA action and d) whether Cl- secretion is
mediated by a basolateral NKCC and/or KCC and an apical
CFTR Cl- channel. Our findings establish that the
SCCD is a site in the inner ear for PKA-mediated Cl-
transport, that this transport depends on NKCC1 and
another Cl- uptake process (perhaps KCC), that apical
CFTR is likely involved and that it is enhanced by
glucocorticoid-receptor activation.
Results
Adenylyl cyclase activator, cAMP analogs, and
phosphodiesterase inhibitors stimulate Isc
The SCCD epithelium actively contributes to endolymph
homeostasis by Cl- secretion under control of β2-adrenergic
receptors via a cAMP pathway [6], like other epithelia that
are known to secrete Cl- upon stimulation by β-adrenergicreceptor activation [22-26]. Forskolin (adenylyl cyclase
activator) [6] (Figure 1A & B), cell permeable cAMP
analogs (8-Br-cAMP and 8-pCPT-cAMP [100 μM])
(Figure 2A & B), the non-selective phosphodiesterase
inhibitor 3-isobutyl-1-methylxanthine (IBMX; 250 μM)
(Figure 2C), and the cAMP-specific phosphodiesterase-
4 (PDE4) inhibitor RO-20-1724 (100 μM) (Figure 2D)
increased Isc in the presence of apical amiloride (10 μM),
an inhibitor of the epithelial Na+ channel. The maximal
forskolin-stimulated Isc was 0.58 ± 0.06 μA/cm2 (n=38)
(Figure 1B). In the present series of experiments
(Figures 2B,C,D), amiloride produced no significant
changes in Isc in the absence of steroids, although in a
previous larger series of experiments there was a small
(15%) but significant decrease in Isc [17]. The initial
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Figure 2 Membrane-permeable cAMP analogs and phosphodiesterase inhibitors increase Isc. A) Summary of concentration-response of Isc
to 8-Br-cAMP (n = 3–4) on both sides after prior application of 10 μM apical amiloride, EC50 = 180 μM and Hill coefficient 3.0. B) Summary of
response of Isc to 8-pCPT-cAMP (8-pCPT; 100 μM; n = 4) on both sides in the presence of apical amiloride (10 μM); no further stimulation by
subsequent forskolin (FSK, 10 μM). C) Summary of response of Isc to 3-isobutyl-1-methylxanthine (IBMX; 250 μM; n = 3) on both sides and D) RO-
20-1720 (RO-20; 100 μM; n = 3) on both sides after prior application of apical amiloride (10 μM). Summary data are mean ± SEM; *, P < 0.05; NS,
not significant; compared to bar immediately to the left.
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http://www.biomedcentral.com/1472-6793/13/6transepithelial resistance (Figure 1B) was 4.7 ± 0.6 kΩ-cm2
(n=3) and decreased significantly with 30 μM forskolin to
3.1 ± 0.3 kΩ-cm2 (n=3).
The lipid-soluble drugs forskolin, 8-pCPT-cAMP, RO-20
-1724, 3-isobutyl-1-methylxanthine (IBMX), were added to
both the apical and basolateral baths. Amiloride was added
to only the apical side and bumetanide to the basolateral
side. Amiloride had no significant effect on Isc, whereas
subsequent addition of both forskolin (Figure 1) and 8-
Br-cAMP (Figure 2A) increased Isc in a concentration
dependent manner with an EC50 of about 0.8 μM and
180 μM respectively. Forskolin showed no additional
effect after prior stimulation by either 8-pCPT-cAMP
(100 μM) (Figure 2B) or by RO-20-1724 (100 μM)
(Figure 2D), demonstrating constitutive activity of
adenylyl cyclase in SCCD epithelium.Glucocorticoids increase forskolin-stimulated Isc
We investigated whether forskolin-stimulated Cl- secre-
tion was altered by glucocorticoid treatment (24 hr). As in
the absence of dexamethasone, increasing intracellular
cAMP in dexamethasone-treated epithelia by exposure to
8-pCPT-cAMP in the presence of amiloride (10 μM) led
to an increased Isc (representative recording in Figure 3).
Similar responses were seen with forskolin (10 μM), 8-
Br-cAMP (100 μM) and IBMX (250 μM) (data not
shown). The glucocorticoid-stimulated Na+ absorption via
apical sodium channels (ENaC) was blocked by amiloride,
which decreased Isc by 81 – 92% [17]; the remaining
current was due to Cl- secretion [6].
The concentration-dependence of natural and syn-
thetic glucocorticoids was determined (Figure 4). Inter-
estingly, the stimulation by forskolin was significantly
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Figure 3 Stimulation of Cl- secretion by cAMP after exposure to
dexamethasone. Representative trace of response of VT to apical
amiloride and the membrane-permeable cAMP analog 8-pCPT-cAMP
on both sides after incubation with dexamethasone (100 nM, 24 h).
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http://www.biomedcentral.com/1472-6793/13/6greater after treatment with 100 or 300 nM dexametha-
sone, as observed previously with single concentrations of
dexamethasone and forskolin [17]. Similarly, the stimula-
tion of Isc by forskolin was significantly greater after 24 hr
treatment with the other glucocorticoids (hydrocortisone,
corticosterone, and prednisolone) and the mineralocortic-
oid aldosterone in the continued presence of amiloride
(Figure 4). The transepithelial resistance was significantly
reduced by about one third after exposure to effective
concentrations of glucocorticoids (ANOVA analysis of
Table two in [17]), as would be expected after insertion of
a conductive pathway (epithelial sodium channels) in the
apical membrane.
The natural and synthetic glucocorticoids stimulated
within their respective physiologic and therapeutic
ranges [17], while aldosterone was only effective at con-
centrations much higher than found under normal
physiologic conditions [17].
Glucocorticoids increase forskolin-stimulated Isc by
activation of glucocorticoid receptor
We investigated whether dexamethasone, hydrocorti-
sone, and aldosterone increased FSK-stimulated Isc by
activation of glucocorticoid receptors and/or mineralo-
corticoid receptors. SCCD epithelia were incubated in
the presence of dexamethasone (100 nM), hydrocorti-
sone (1 μM) or aldosterone (1 μM) alone or in the pres-
ence of receptor antagonists. Mifepristone significantly
reduced the effects of dexamethasone, hydrocortisone
and aldosterone (Figure 4A,D,E), consistent with action
of all of these corticosteroids at the glucocorticoid receptor.
Mifepristone is also known to be an antagonist of the pro-
gesterone receptor; however, progesterone (10–1000 nM)
had no effect on forskolin stimulation (Figure 4F). The
mineralocorticoid receptor antagonist spironolactone had
no significant effect on dexamethasone-, hydrocortisone- oraldosterone-treated epithelia (Figure 4A,D,E), consistent
with a lack of involvement of mineralocorticoid receptor in
the increase of the FSK-stimulated Isc in these cells. These
findings suggest that corticosteroids increase forskolin-
stimulated Isc (cAMP-mediated Cl
- secretion) solely by acti-
vation of glucocorticoid receptors in SCCD epithelia.
PKA activator stimulates Isc
It is known that cAMP-dependent Cl- secretion in many
epithelia is mostly mediated through activation of protein
kinase A (PKA) [7]. We therefore investigated whether
PKA activation increases Isc in SCCD. Indeed, apical and
basolateral addition of PKA activator N6-BNZ-cAMP stim-
ulated Isc at 30, 100, 300 and 1000 μM after prior inhibition
of Na+ transport with apical amiloride (10 μM) (Figure 5).
Blockers of basolateral Na+-K+-2Cl- and K+-Cl-
cotransporters inhibit forskolin and/or forskolin + IBMX-
stimulated Isc
We have previously shown that both Ba2+-sensitive K+
channels and ouabain-sensitive Na+-K+-ATPase are in-
volved in Cl- secretion by SCCD [6]. However, the partici-
pation of Na+-K+-2Cl- and K+-Cl- cotransporters is not
known. Therefore, we investigated whether these transport
proteins are involved in cAMP-mediated Cl- secretion. Un-
treated and dexamethasone (100 nM; 24 hr)-treated SCCD
epithelia were stimulated with apical and basolateral
forskolin and forskolin + IBMX respectively, followed by
application of blockers of ion transporters to the basolateral
side. Na+-K+-2Cl- cotransporter inhibitor bumetanide
(50 μM) partially decreased the magnitude of forskolin
(5 μM) + IBMX (125 μM)-stimulated Isc (Figure 6A).
Bumetanide (10 & 50 μM) also decreased the forskolin
(10 μM)-stimulated Isc by 20 ± 2% (10 μM; n = 8) and
18 ± 5% (50 μM; n = 3) (data not shown). Similarly, the
K+-Cl- cotransporter blocker [(dihydroindenyl)oxy]alkanoic
acid (DIOA, 100 μM) partially inhibited the forskolin +
IBMX-stimulated Isc (Figure 6B). Interestingly, DIOA and
bumetanide, when added to the bath cumulatively, com-
pletely inhibited all of the forskolin + IBMX-stimulation,
returning Isc to the level observed with amiloride (Figure 6C).
These findings are consistent with the presence of Na+-
K+-2Cl- and K+-Cl- cotransporters at the basolateral mem-
brane and their participation in Cl- secretion by SCCD
epithelium, although DIOA is lipophilic and could cross to a
KCC on the apical membrane. However, the observed effect
is not likely a result of action of DIOA on an apical KCC
since transport of Cl- by an apical KCC would also result in
a similar rate of K+ secretion, and no transepithelial K+ (Rb+)
flux was detected from cAMP-stimulated SCCD [6].
Expression of KCC and WNK isoforms
Additive inhibition of Isc by bumetanide and DIOA sug-
gested dependence of electrogenic Cl- transport in SCCD
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Figure 4 Response of forskolin-stimulated Isc to corticosteroids. Summary data of responses to forskolin (10 μM) after incubation (24 h) in
steroids or steroids + receptor antagonists at the concentrations shown. A) dexamethasone (Dex) ± spironolactone (Spi) or mifepristone (mif);
B) prednisolone (Pred); C) corticosterone (Cort); D) hydrocortisone (HC) ± spironolactone (Spi) or mifepristone (mif); E) aldosterone (Aldo) ±
spironolactone (Spi) or mifepristone (mif); F) progesterone (Prog). The horizontal dashed lines show the reference levels for
statistical comparisons.
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http://www.biomedcentral.com/1472-6793/13/6on expression of NKCC and KCC. The basolateral iso-
form of NKCC, (NKCC1/Slc12a2 Affymetrix probe set
1367853_at), was shown to be present in a gene array
of SCCD and the apical isoform (NKCC2/Slc12a1
Affymetrix probe set 1368548_at) was absent [27]. Not
all isoforms of KCC were identified on the gene chips;
we tested for expression of transcripts with RT-PCR
and observed expression of KCC1, KCC3a, KCC3b and
KCC4; but, KCC2 was absent (Table 1).
It is known that genetic mutations in the kinase WNK1
and WNK4 cause a disease featuring hypertension and
hyperkalemia and the etiology appears to be related to
regulation of NKCC and KCC (reviewed in [49]). We ob-
served that SCCD expresses WNK1 but only very low or
absent WNK4 (Table 2).
Blockers of apical Cl- transport inhibit forskolin and/or
forskolin + IBMX-stimulated Isc
Cl- secretion across the apical membrane in many epi-
thelia is mediated by the CFTR Cl- channel [8,10]. Na+
currents were blocked by amiloride (100 μM) in dexa-
methasone (100 nM, 24 hr)-treated SCCD epithelia. Isc
was then stimulated with apical and basolateral forskolin
(5 μM) + IBMX (125 μM), followed by apical addition of
blockers of Cl- transporters. Non-selective Cl- channel
inhibitors DPC (1 mM) and flufenamic acid (5 μM)
(Figure 7A) partially inhibited the stimulated Isc. The
CFTR Cl- channel blocker CFTRinh-172 (5 μM or 30 μM)I s
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Figure 5 PKA activation of Isc. Summary of response of Isc to the
PKA activator N6-BNZ-cAMP (n = 3) after treatment with
dexamethasone in the presence of apical amiloride (10 μM).
Summary data are mean ± SEM; *, P < 0.05; compared to bar prior
to addition of activator. Note a break in the Y-axis.[28] partially inhibited the forskolin (10 μM) and forskolin
(5 μM) + IBMX (125 μM)-stimulated Isc in both the ab-
sence and presence of dexamethasone (100 nM, 24 hr;
Figure 7B, left and right panels). Taken together, these
results suggest that CFTR Cl- channels are functionally
expressed at the apical membrane and account for at least
part of the Cl- secretion by SCCD epithelium, although
CFTR appears to not be essential for vestibular function
under normative conditions (see below). The observation
of the presence of mRNA transcripts of CFTR in gene
arrays of rat primary cultures (Affymetrix Probe set
1384960_at [27]) is consistent with that interpretation.
SCCD from CFTR+/− mice showed an increase in
response of Isc to a β2-adrenergic receptor agonist
isoproterenol (100 nM) and a mixture of forskolin and
IBMX (Figure 8, top panel). Heterozygous CFTR mice
are known to have an ion transport profile similar to
wild-type mice [29]. A mixture of DIOA (KCC inhibitor)
and bumetanide (NKCC inhibitor) completely inhibited
the increased Isc by forskolin + IBMX (Figure 8, top
panel). This result is consistent with the results shown
above in rat SCCD primary cultures (Figure 6C). On the
other hand, SCCD from CFTR−/− mice lacked response
to both isoproterenol (10 μM) and a mixture of forskolin
and IBMX, suggesting that all of the cAMP-stimulated
Isc is mediated by, or dependent on, CFTR in mouse
SCCD (Figure 8, top panel). The vestibular functional
phenotype, as assessed by Rota-Rod, of the CFTR−/−
mice did not differ significantly from the CFTR+/− mice
(Figure 8, bottom panel), in spite of the profound differ-
ence in stimulated Isc (above).
Discussion
Sensory transduction of acceleration in the vestibular
labyrinth is mediated by modulation of K+ currents
through sensory cells, where the K+ originates from the
high-[K+] luminal fluid. Secretion of K+ is controlled by
β-adrenergic stimulation (among other signal pathways)
[30,31] and it is to be expected that secretion of the pri-
mary anion would also be regulated by the same ago-
nists. Movements of anions would be expected to be
transcellular since the paracellular pathway must be
extremely tight in this epithelium to support the large
ion concentration gradients. Cl- secretion by the semicir-
cular canal duct (SCCD) in the vestibular labyrinth is
stimulated by cAMP as second messenger [6] and similar
mechanisms have been proposed in the cochlea [32,33],
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Figure 6 Inhibition of forskolin-stimulated Isc by bumetanide
and DIOA. A) Summary of inhibition by basolateral bumetanide
(BUM) (n = 11) of cAMP-stimulated Isc (forskolin, FSK + IBMX).
Epithelia were incubated in dexamethasone and Na+ transport was
inhibited with apical amiloride before stimulation by cAMP. Note
that Isc does not return after only bumetanide to the basal Cl
-
secretion rate in amiloride (dotted line). B) Representative recording
of VT and the response to apical amiloride forskolin + IBMX,
basolateral DIOA and basolateral bumetanide (BUM). C) Summary of
response of Isc to DIOA and bumetanide (BUM) (n = 3) after
stimulation by forskolin+ IBMX. Na+ transport was inhibited with
apical amiloride before stimulation. Note that Isc returns after both
DIOA and bumetanide to the basal Cl- secretion rate in amiloride
(dotted line). Summary data (A and C) are mean ± SEM; *, P < 0.05
compared to bar immediately to the left; NSA, not significantly
different from amiloride.
Table 1 RT-PCR demonstration of the presence of KCC1,
KCC3a, KCC3b, KCC4 and absence of KCC2 in rat SCCD
primary cultures
Ct, average
Tissue 18S KCC1 KCC2 KCC3a KCC3b KCC4
rSCCD 26.4 BT 25.0 27.3 26.7
rat kidney 14.2 25.9 – 23.3 24.5 26.3
rat brain – – 22.6 – – –
blank 35.0 30.2 BT BT 32.3 35.8
BT, Below Threshold fluorescence at end of 38 thermocycles. Ct values are
based on duplicate runs of 4 samples SCCD and duplicates of control tissue
total RNA. The difference between Ct values of duplicates varied by 0.3 ± 0.04
(n=26) with a range from 0.0 to 0.8.
Pondugula et al. BMC Physiology 2013, 13:6 Page 7 of 14
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yet been unambiguously determined (see [34]).
The SCCD is an epithelial domain that has a high ratio
of surface area to endolymph volume and would there-
fore be a strong candidate for a site of effective ion
homeostasis. Indeed, it was recently shown that these
cells also absorb Na+ via the epithelial sodium channel
(ENaC) under glucocorticoid receptor control [17,18]
and absorb Ca2+ via an epithelial Ca2+ channel [35], in
addition to their role in Cl- secretion.
We determined in the present study that cAMP acts
via PKA, whose target may be an apical CFTR Cl chan-
nel [6]. Evidence supporting the involvement of CFTR
include inhibition of Cl- secretion (cAMP-stimulated Isc)
by the poorly-specific inhibitors flufenamic acid and
DPC and by the specific inhibitor CFTRinh-172. Partial
inhibition in rSCCD by CFTRinh-172 is consistent with
reports of significant but only partial inhibition in avian
proximal tubule at 20 μM [36]. In addition, mRNA mes-
sage for CFTR was found to be present in the rat pri-
mary cultures of SCCD (GEO database, Accession
GSE6196, [27]). The observation of cAMP-stimulated Isc
in mouse canals extends the findings in gerbil and rat
[6] to another rodent species. The absence of cAMP-
stimulated Isc in CFTR knockout mice is consistent with
an essential role of CFTR in canal Cl- secretion, although
there is no strict proof ruling out the unlikely occurrence
of dissection damage to only the knockout mouse canals.Table 2 RT-PCR demonstration of the presence of WNK1
and absence of WNK4 in rat SCCD primary cultures
Tissue 18S WNK1 WNK4
rSCCD 13.4 24.7 31.6
rat kidney 14.7 25.0 26.0
blank 34.4 BT 35.2
Ct, average. BT, Below Threshold fluorescence at end of 38 thermocycles. Ct
values are based on duplicate runs of 4 samples SCCD and duplicates of rat
kidney as a control tissue. The difference between Ct values of duplicates
varied by 0.6 ± 0.09 (n=36) with a range from 0.0 to 2.1.
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and flufenamic acid (FFA) significantly reduced cAMP-stimulated Isc.
B) CFTRinh-172 significantly reduced cAMP-stimulated Isc in both the
absence and presence of dexamethasone. FSK, forskolin; CF, CFTRinh-
172. *, P < 0.05.
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Figure 8 Short circuit current and balance in CFTR knockout
mice. (top panel) Vibrating Probe recordings of Isc from native SCCD
from heterozygote (CFTR+/−) and CFTR knockout (CFTR−/−) mice
(n=3 each). ISO, Isoproterennol (10 μM); F, Forskolin; I, IBMX; D, DIOA;
B, Bumetanide. The control bath solution contained Amiloride (10
μm). Perfusion was returned to control solution after isoproterenol.
*, significant change in current by treatment; P < 0.05. NS, not
significant. (bottom panel) Balance function of heterozygote (CFTR
+/−) and CFTR knockout (CFTR−/−) mice was tested with a rota-rod
apparatus. No significant difference was found between the two
groups (n=5 each).
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sons with dysfunctional CFTR (cystic fibrosis) [37,38]
and no reports of vertigo in this population. Our results
with vestibular tests of CFTR knockout mice are consist-
ent with that observation. It may be, however, that this
anion transport system is not by itself essential for nor-
mal inner ear function, but may be necessary in times of
systemic stress when β-adrenergic agonist levels are
elevated, but this proposition remains to be tested.
The results here demonstrated increased Isc by stimu-
lation of the cAMP signal pathway in several ways:
through increased cAMP production (forskolin stimula-
tion of adenylyl cyclase), addition of exogenous cAMP
analogs (8-Br-cAMP and 8-pCPT-cAMP), and inhibition
of cAMP catabolism (IBMX and RO-20-1724 inhibition
of phosphodiesterase). The action of all of these agents
has been well-documented in other cells [11-13,19-21].
Increased Cl- secretion by inhibition of phosphodiester-
ase implies that the adenylyl cyclase is constitutively
active in the SCCD epithelium in the absence of β-
adrenergic agonists, and is therefore consistent with the
earlier observation of constitutive low-level Cl- secretion
[6]. Stimulation of Cl- secretion has been reported in
mouse jejunum, guinea pig distal colon, T84 monolayers
and human colonic epithelial cells by phosphodiesterase
inhibition [39-42]. Of particular interest is the finding
that phosphodiesterase inhibition did not elevate Cl-secretion in the absence of exogenous stimulation of
adenylyl cyclase in T84 epithelial monolayers [41]. This
is in contradistinction to our observations in rat semicir-
cular canal primary cultures (vide infra and [6]).
The responsiveness of adenylyl cyclase and phospho-
diesterase to multiple physiological challenges is related to
the presence of multiple families of isoforms with tissue-
specific localization [11-13]. Ten isoforms of adenylyl
cyclase (AC; membranous AC1-9 and soluble AC) have
been identified in mammalian cells [11]. In SCCD, the
non-selective adenylyl cyclase activator forskolin, which is
known to activate all identified adenylyl cyclase isoforms
with varying sensitivity [11,43,44], stimulated Cl- secre-
tion. Gene array results showed expression of transcripts
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tested (AC2, AC3, AC4, AC5, AC6, and AC8) using
Affymetrix Rat Genome 230 2.0 Array chips [27]. How-
ever, it is not known whether other isoforms that were not
represented on the gene array are expressed in SCCD.
Eleven families of phosphodiesterases (PDE1 to
PDE11) have been identified in mammalian cells, with
each family having several isoforms [13]. Phosphodies-
terases show three types of substrate specificity [13].
The PDE4, PDE7, and PDE8 families hydrolyze cAMP
specifically. PDE5, PDE6, and PDE9 are cGMP specific
and PDE1, PDE2, PDE3, PDE10, and PDE11 are dual
substrate phosphodiesterases i.e. they hydrolyze both
cAMP and cGMP. In SCCD, both the non-selective
phosphodiesterase inhibitor IBMX and the selective
PDE4 inhibitor RO-20-1724 [19] stimulated Cl- secre-
tion. Gene array results showed expression of the tran-
scripts for PDE4 and PDE7 isoforms but not PDE8 in
SCCD [27]. Expression of PDE4 at the transcript level is
consistent with RO-20-1724 stimulation of Isc.
Glucocorticoids are known to affect cAMP metabol-
ism and potentiate cAMP-mediated responses, including
salt and water transport by activation of the glucocortic-
oid receptor [16,19-21]. It is known that glucocorticoids
stimulate anion transport, including Cl- in mammalian
ileal mucosa, by increasing the concentration of cyclic
nucleotides [16]. Glucocorticoids elevate cellular cAMP
levels by regulating the activity of both adenylyl cyclases
and phosphodiesterases, predominantly by suppressing
the activity of phosphodiesterases [19,20]. It is not
known if glucocorticoids increase cAMP-mediated Cl-
secretion in SCCD epithelium by a similar mechanism.
Glucocorticoids increase cAMP-mediated Cl- secretion
in SCCD epithelium by activation of exclusively the
glucocorticoid receptor. However, the exact mechanism
of potentiation of cAMP response is not known. The
stimulation of cAMP-mediated Isc could not have been a
result of the increase in glucocorticoid-activated ENaC
function [17], since increased Na+ conductance would
depolarize the cell, which in turn would reduce the out-
ward driving force for Cl- across the apical membrane,
in contrast to observations. In addition, Na+ absorption
was blocked by amiloride in these experiments. Another
putative mechanism of action of glucocorticoids in
SCCD is regulation of NKCC expression, as observed in
vascular smooth muscle and trabecular meshwork cells
[45,46]. However, there was no change in expression of
NKCC1 in SCCD after incubation with 100 nM dexa-
methasone for 24 h [27]. The molecular mechanism for
glucocorticoid-increased cAMP-mediated Cl- secretion
in SCCD epithelium has not yet been resolved.
One pathway of corticosteroid action is via the kinases
SGK1 and WNK1 [47] among other kinases involved in
regulation of ion transport such as SPAK and OSR1[48]. Our gene array of rat SCCD cultures [27] showed
SPAK or Stk39 to be present (1387059_at based on
Genbank NM_019362) and minimally down-regulated
1.2-fold by dexamethasone. There were no probe sets
identified on the chips for OSR1. WNK1 is downstream
from SGK1 and is implicated in the control of both
NKCC and KCC transporters and thereby their roles in
Cl- transport [49]. The expression of WNK1 in the
SCCD may therefore be involved in the regulation of Cl-
secretion in SCCD through these two transporters. The
transcript expression for WNK4 was nearly absent.
Complete additive inhibition of the cAMP-stimulated
Isc by bumetanide and DIOA is consistent with the par-
ticipation of both Na+-K+-2Cl- and K+-Cl- cotransporter
in Cl- cotransport. The concentration of bumetanide
used fully inhibits NKCC1 but has no effect on KCC1
and KCC4 [50,51]. Similarly, DIOA is a potent well-
established KCC transport inhibitor (IC50 = 10–40 μM)
that is without effect on NKCC [52,53] and has been used
as a specific KCC inhibitor in the range 30 – 100 μM
[53-55]. However, DIOA has also been observed in several
epithelia to have diverse effects [56-59].
The canonical interpretation that the effect of DIOA is
a result of inhibition of a KCC, however, is problematic.
Foremost, the KCC would be operating “backwards”
from its most-commonly observed mode and if this were
indeed the case it would necessitate an extremely low
intracellular [Cl-]. A low intracellular concentration of
the secreted ion species (Cl-) would not favor a strong
efflux across the apical membrane. Although most
cells operate KCC transporters as cellular efflux path-
ways, Payne calculates that some neuronal cells have
sufficiently-low intracellular [Cl-] to thermodynamic-
ally drive influx of KCl [60]. The membrane potential,
intracellular [K+] and [Cl-] of SCCD epithelial cells is
not known, so it is not possible at this time to evaluate
whether these cells are able to support concurrent
basolateral KCC electroneutral influx and apical elec-
trogenic Cl- secretion. The discussion by Payne [60]
shows that at the normal extracellular [K+] of about 4
mM, the intracellular [Cl-] would need to be about 5
mM or less; a highly unlikely constellation. An eleva-
tion of extracellular [K+] at the canal epithelium due
to hair cell stimulation is also highly unlikely since the
hair cells are located remotely from the canals and
excess K+ would be removed from perilymph by vestibu-
lar dark cells recycling the K+ back into the lumen.
The observation that basolateral bumetanide causes only
a partial inhibition of cAMP-stimulated Cl- secretion at 50
μM suggests the existence of a parallel Cl- uptake mechan-
ism. Block of the remaining secretion by DIOA points to a
KCC, subject to the caveats given above. An alternative ex-
planation is that DIOA is not a specific inhibitor for KCC
in SCCD and either blocks another Cl- uptake mechanism
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tions or acts broadly on active transport through inhibition
of metabolic processes. This last suggestion has been ob-
served with another lipid-soluble weak acid, the Cl- channel
blocker NPPB, restricting its use to <100 μM [61]. In
addition, DIOA has been shown to interfere with ATP re-
covery after metabolic insult and to release cytochrome c
from isolated mitochondria at the concentration used here
[62]. Nonetheless, if this is the basis for action of DIOA in
the semicircular canal epithelium, the metabolic interfer-
ence is not complete (Figure 6) and the likely involvement
of a parallel Cl- uptake pathway in rat canal remains.
In summary, our results are consistent with the follow-
ing cell transport model of regulated Cl- secretion by
SCCD (Figure 9). A basolateral Na+-K+-ATPase removes
Na+ from the cell and brings in K+, which is energized
by ATP. The resulting Na+ concentration gradient drives
the basolateral influx of K+ and Cl- along with the recir-
culating Na+ ions via the bumetanide-sensitive NKCC1.
Cl- would be secreted across the apical membrane
through Cl- channels that may include CFTR as a chan-
nel or transport modulator. The rate of secretion is
controlled by glucocorticoids and β2-adrenergic signal-
ling via cAMP and PKA.
Conclusions
The rat semicircular canal duct epithelium expresses
three major ion transport systems, including a β2-adren-
ergic receptor-stimulated Cl- secretion [6]. We have
demonstrated here that Cl- secretion is under control
of a PKA-mediated signal pathway that depends onBasolateral
BumetanideBa2+
K+
Na+ K+2Cl-
3Na+
2K+
CFTR 
PKA
Apical
FSK
ATP
CFTRInh-172
8-Br-cAMP
8-pCPT-cAMP
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N6-Bnz-cAMP
(activator of PKA)
ATPNKCC
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Figure 9 Proposed cell model for cAMP/PKA-mediated Cl- secretion b
by NKCC (Na+-K+-2Cl- cotransporter). A Na+-K+-ATPase and Ba2+-sensitive K
negative cell membrane potential that drives Cl- exit across the apical mem
from activation of a basolateral β2-adrenergic receptor (β2-AR; activated by
messenger pathway (Gs-protein activation of adenylyl cyclase (AC) which c
catabolizes cAMP and can be inhibited by IBMX and RO-20-1720 (RO-20). T
activation of intracellular glucocorticoid receptors (not shown) after chronicbasolateral Cl- uptake via NKCC and (KCC?) trans-
porters and that it is enhanced by activation of gluco-
corticoid receptors. Interestingly, NKCC does not
appear to contribute to ENaC-mediated Na+ absorption
[17] in the same cells. The role of the β2-adrenergic re-
ceptor/cAMP pathway in inner ear function remains
unknown but is likely activated under stress.Methods
All experiments were performed on primary cultures of
rat SCCD, except the measurements of short circuit
current from native canals and vestibular function that
were performed on CFTR mutant mice.Cell cultures of rat SCCD epithelium
Primary cultures of neonatal Wistar rat SCCD epithe-
lium were produced as described previously [6]. Briefly,
animals were anesthetized and sacrificed according to a
protocol approved by the Kansas State University Insti-
tutional Animal Care and Use Committee. SCCD epithe-
lial cells were microdissected from isolated temporal
bones. Isolated cells, exclusive of connective tissue and
common crus, were seeded on 6.5 mm diameter perme-
able (4 μm) Costar (#3470) Transwell supports and
cultured in DMEM/F12 medium (Invitrogen 12500–062;
http://www.invitrogen.com/site/us/en/home/support/
Product-Technical-Resources/media_formulation.60.
html) supplemented with 5% fetal bovine serum, 26.8
mM NaHCO3
- , penicillin (100 U/ml) and streptomycin
(100 μg/ml). Cultures treated with steroids, in the(?)
cAMP
AC
-AR
Gs
PDE
IBMX/RO-20
AMP
Iso
y SCCD epithelium. Cl- is taken up across the basolateral membrane
+ conductance in the basolateral membrane is thought to create a
brane via a Cl- channel, likely CFTR. Cl- secretion is stimulated by PKA
agonists such as isoproterenol, ISO) coupled to a cAMP second
an also be directly activated by forskolin (FSK). Phosphodiesterase (PDE)
he cAMP-dependent Cl- secretion pathway is further stimulated by
exposure to glucocorticosteroids.
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24 h unless otherwise stated.Reagents
Amiloride (#A-7410, Sigma), forskolin (#F-6886, Sigma),
spironolactone (#S-3378, Sigma), mifepristone (#M-8046,
Sigma), corticosterone (#C-2505, Sigma), prednisolone
(#6004, Sigma), bumetanide (#B-3023, Sigma), RO-20-1724
(#557502, Calbiochem), 3-isobutyl-1-methylxanthine (IBMX;
#I-7018, Sigma), flufenamic acid (#F-9005, Sigma), CFTR inh-
172 ([28](gift from Dr. Bruce Schultz), and [(dihydroindenyl)
oxy]alkanoic acid (DIOA; # D-129, Sigma) were dissolved in
DMSO. Progesterone (#P-8783, Sigma), and aldosterone
(#215360050, Acros Organics, New Jersey) were dissolved in
absolute ethanol. DMSO or ethanol alone had no effect on
electrical parameters in Ussing chamber experiments.
Cyclodextrin-encapsulated dexamethasone (#D-2915,
Sigma), hydrocortisone (#H-0396, Sigma), isoproterenol
(#I-6504, Sigma), 8-Br-cAMP (#203800, Calbiochem), 8-
pCPT-cAMP (#C-3912, Sigma), and N6-Benzoyl-Adenosine
30,50-cyclic Monophosphate, Sodium Salt (N6-BNZ-cAMP;
#116802, Calbiochem) were dissolved in water.Mice breeding and maintenance
CFTR heterozygous parents in a C57BL/6 background
were bred and the offspring were genotyped for CFTR+/+,
CFTR+/− or CFTR−/− All the animals were maintained on
Colyte in water to avoid intestinal impaction [63].Table 3 Gene-specific primers
Gene Primers 50—30 GenB
18S S: GAG GTT CGA AGA CGA TCA GA BK0
AS: TCG CTC CAC CAA CTA AGA AC
KCC1 S: GTT CGC CTC ACT CTT CCT GGC U
AS: TGG GCC ACC ACA TAC AGG GA
KCC2 S: CAT CAC AGA TGA ATC TCG GG U
AS: TTC TCT GGG TCT GTC TCC C
KCC3a S: CCT CGC CTC CTC ACC TTT GC AF2
AS: TCA CTC TGA CGC CAG CCA TTG
KCC3b S: AGT AAA AGC CCG GAT TCA GG AF2
AS: ATG AAA GTA CCC ATT TGG GG
KCC4 S: AGG AAG CTG CTG AGC GCA C AF0
AS: CAG CAT TGT ACA GGT GCA GC
WNK1 S: ACC AGA AAG CCT CAT GTA AGC C NM
AS: GTC CGC AGG GAA CGT CAT TG
WNK4 S: CAC CTC CCG CCG CAA CAG NM
AS: TCC ACA CAG CAA AGA GCA CCC
Primers designed on mouse sequences also specifically recognized and amplified th
recognize their targets.Dissection of mouse SCCD
CFTR+/− and CFTR−/− mice (34–39 days old) [63] were
anesthetized with sodium pentobarbital (50–100 mg/kg; i.p.)
and sacrificed under a protocol approved by the Institutional
Animal Care and Use Committee of Kansas State University.
The temporal bones were removed and SCCD without
common crus were dissected in HEPES-buffered saline.
The SCCD were mounted in a 200 μl perfusion cham-
ber on the stage of an inverted microscope (Nikon
ECLIPSE TE 300) and continuously perfused at 37°C with
HEPES-buffed solution at an exchange rate of 180 μl/sec.Electrophysiological measurements
Isc from Primary cultures of rat SCCD
SCCD epithelia were bathed in HEPES-buffered solution
equilibrated with air. The composition was (in mM) 150
NaCl, 3.6 KCl, 1 MgCl2, 0.7 CaCl2, 5 glucose, and 10
HEPES, pH 7.4. Transepithelial voltage (VT) and resist-
ance (RT) were measured from confluent monolayers of
SCCD in an Ussing chamber under current clamp
(ΔI=1 μA) mode as described previously [17,18]. The
equivalent Isc was calculated from Isc = VT/RT. Isc was
measured either in the absence of steroids (Figure 1, 2,
7B left) or after 24 h incubation with steroid. Steroid-
stimulated Na+ current was blocked with amiloride be-
fore measurement of cAMP-stimulated Isc. Cytosolic
cAMP levels were raised by stimulation of adenylyl cyclase
with forskolin, block of phosphodiesterase with IBMX or
RO-20-1724 or a combination of forskolin and IBMX,ank # (species) Amplicon size (bp) Source
00964 (many) 316 [65]
55815 (rat) 419 [66]
55816 (rat) 213 [66]
11854 (mouse) 284 This study
11855 (mouse) 330 [66]
87436 (mouse) 443 [66]
_053794 (rat) 301 This study
_175579 (rat) 347 This study
e corresponding rat genes. All primer sets were validated to specifically
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hydrocortisone, aldosterone, forskolin, 8-pCPT-cAMP,
N6-BNZ-cAMP, spironolactone, mifepristone, cortico-
sterone, prednisolone, progesterone and [(dihydroindenyl)
oxy]alkanoic acid (DIOA) were added to both the apical
and basolateral baths. Amiloride was added to only the
apical side and bumetanide to the basolateral side.
Isc from mouse native canal ducts; Voltage-sensitive
vibrating probe recordings
The vibrating probe technique was identical to that previ-
ously described [34,64]. Briefly, the current density was
monitored from mouse SCCD by vibrating (200–400 Hz)
a platinum-iridium wire microelectrode with a platinum-
black tip positioned 20 μm from the basolateral surface of
the SCCD with computer-controlled stepper-motor ma-
nipulators (Applicable Electronics, Forest Dale, MA) and
probe software (ASET version 2.00, Science Wares, East
Falmouth, MA). The bath references were 26-gauge
Pt-black electrodes. The phase-locked signal from the
electrode was detected by phase-sensitive amplifiers, digi-
tized y (0.5 Hz, 16 bit), and the output was expressed as
current density at the electrode. HEPES-buffered solution
was used as the bath.
Vestibular function test
4 sets of littermate-matched CFTR+/− and CFTR−/− mice
(mean age = 56 d) were tested 4 times/day (with a five
minute rest between tests) over five days. The RotaRod
(Series 8, IITC, Woodland Hills, CA) used a 32 mm
diameter rod and was programmed to start at 4 RPM,
increasing to 40 RPM over 1 minute. All mice were
placed on the rod before rotation was initiated and the
time until falling was recorded. The instrument was
modified by placing a landing cushion on the platform
of the timer stop switch. The daily mean time for each
mouse was used to calculate the mean and standard
error of each group. After the last run of each day, all
homozygous mice were given a 1 ml saline injection to
prevent dehydration.
RNA isolation and RT-PCR
Total RNA was extracted from SCCD primary cultures
using RNeasy Micro Kit and the quality and quantity
were determined as described previously [18]. RT-PCR
was performed on total RNA as described previously
using a One Step RT-PCR Kit following the manufac-
turer’s protocol (#210210, Qiagen) [18].
Gene-specific primers for KCC and WNK isoforms
were based on GenBank sequences (Table 3) and were
verified to amplify the intended targets. Reverse tran-
scription (RT) was performed on 10 ng of total RNA for
30 min at 50°C and 15 min at 95°C. RT was followed by
38 PCR cycles. Each PCR cycle consisted of 95°C for 1min, 55°C for 1 min and 72°C for 1 min. To exclude the
possibility of genomic DNA amplification during the
PCR reaction, RT negative controls were performed
(−RT). PCR products were run on 2% agarose gels and
detected by ethidium bromide. Purified PCR products
were sequenced to verify the identity of the RT- PCR
products.
Statistical analyses
Electrophysiology data are presented as original record-
ings and as mean values ± SE from n observations. Stu-
dent’s t-test was used to determine statistical significance
of paired and unpaired samples. The Hill equation was
fitted to concentration-response curves by using individ-
ual data points in order to retain appropriate weighting
and presented here plotted with the mean and SEM.
Differences were considered significant for P < 0.05.
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